Resultados de búsqueda - Par, Alajos
- Mostrando 1 - 8 Resultados de 8
-
1
-
2
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C por Szereday, Laszlo, Meggyes, Matyas, Berki, Timea, Miseta, Attila, Farkas, Nelli, Gervain, Judit, Par, Alajos, Par, Gabriella
Publicado 2020Texto -
3
Increased Baseline Proinflammatory Cytokine Production in Chronic Hepatitis C Patients with Rapid Virological Response to Peginterferon Plus Ribavirin por Par, Gabriella, Szereday, Laszlo, Berki, Timea, Palinkas, Laszlo, Halasz, Melinda, Miseta, Attila, Hegedus, Geza, Szekeres-Bartho, Julia, Vincze, Aron, Hunyady, Bela, Par, Alajos
Publicado 2013Texto -
4
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis por Tornai, Tamas, Tornai, David, Sipeki, Nora, Tornai, Istvan, Alsulaimani, Rayan, Fechner, Kai, Roggenbuck, Dirk, Norman, Gary L., Veres, Gabor, Par, Gabriella, Par, Alajos, Szalay, Ferenc, Lakatos, Peter Laszlo, Antal-Szalmas, Peter, Papp, Maria
Publicado 2018Texto -
5
Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis por Tornai, Tamas, Palyu, Eszter, Vitalis, Zsuzsanna, Tornai, Istvan, Tornai, David, Antal-Szalmas, Peter, Norman, Gary L, Shums, Zakera, Veres, Gabor, Dezsofi, Antal, Par, Gabriella, Par, Alajos, Orosz, Peter, Szalay, Ferenc, Lakatos, Peter Laszlo, Papp, Maria
Publicado 2017Texto -
6
Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity? por Papp, Maria, Norman, Gary L., Vitalis, Zsuzsanna, Tornai, Istvan, Altorjay, Istvan, Foldi, Ildiko, Udvardy, Miklos, Shums, Zakera, Dinya, Tamas, Orosz, Peter, Lombay, Bela, Par, Gabriella, Par, Alajos, Veres, Gabor, Csak, Timea, Osztovits, Janos, Szalay, Ferenc, Lakatos, Peter Laszlo
Publicado 2010Texto -
7
IL28B and IL10R −1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort por Pár, Alajos, Pár, Gabriella, Tornai, István, Szalay, Ferenc, Várszegi, Dalma, Fráter, Edit, Papp, Mária, Lengyel, Gabriella, Fehér, János, Varga, Márta, Gervain, Judit, Schuller, János, Nemes, Zsuzsanna, Péterfi, Zoltán, Tusnádi, Anna, Hunyady, Béla, Haragh, Attila, Szinku, Zsolt, Vincze, Áron, Szereday, László, Kisfali, Péter, Melegh, Béla
Publicado 2014Texto -
8
Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy por Hunyady, Béla, Abonyi, Margit, Gerlei, Zsuzsanna, Gervain, Judit, Horváth, Gábor, Jancsik, Viktor, Lengyel, Gabriella, Makkai, Erzsébet, Pár, Alajos, Péter, Zoltán, Pusztay, Margit, Ribiczey, Pál, Rókusz, László, Sarrazin, Christoph, Schneider, Ferenc, Susser, Simone, Szalay, Ferenc, Tornai, István, Tusnádi, Anna, Újhelyi, Eszter, Werling, Klára, Makara, Mihály
Publicado 2018Texto